Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 66(16): 11390-11398, 2023 08 24.
Article in English | MEDLINE | ID: mdl-37561481

ABSTRACT

The anthracycline anti-cancer drugs are intensely used in the clinic to treat a wide variety of cancers. They generate DNA double strand breaks, but recently the induction of chromatin damage was introduced as another major determinant of anti-cancer activity. The combination of these two events results in their reported side effects. While our knowledge on the structure-activity relationship of anthracyclines has improved, many structural variations remain poorly explored. Therefore, we here report on the preparation of a diverse set of anthracyclines with variations within the sugar moiety, amine alkylation pattern, saccharide chain and aglycone. We assessed the cytotoxicity in vitro in relevant human cancer cell lines, and the capacity to induce DNA- and chromatin damage. This coherent set of data allowed us to deduce a few guidelines on anthracycline design, as well as discover novel, highly potent anthracyclines that may be better tolerated by patients.


Subject(s)
Anthracyclines , Neoplasms , Humans , Anthracyclines/pharmacology , Anthracyclines/chemistry , Doxorubicin/pharmacology , Antibiotics, Antineoplastic/chemistry , Topoisomerase II Inhibitors , Chromatin , DNA/metabolism , Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...